Carregant...

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer

Taxane therapy is commonly used in the treatment of metastatic breast cancer. However, most patients will eventually become refractory to these agents. Ixabepilone is a newly approved chemotherapeutic agent for the treatment of metastatic breast cancer. Although it targets microtubules similarly to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Puhalla, Shannon, Brufsky, Adam
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2721395/
https://ncbi.nlm.nih.gov/pubmed/19707381
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!